Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 4/20 | 0.51 |
| ▸ | CA2 | P00918 | 2/20 | 0.51 |
| ▸ | CA7 | P43166 | 2/20 | 0.51 |
| ▸ | CA9 | Q16790 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | HTT | P42858 | 2/20 | 0.44 |
| ▸ | TACR1 | P25103 | 3/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9575742 | 0.79 | TSHR (0.48) | CA1CA2CA7CA9KMT2A | |
| SCHEMBL21843055 | 0.79 | KMT2A (0.62) | CA1CA2CA7CA9KMT2A | |
| SCHEMBL19992384 | 0.79 | KMT2A (0.58) | CA1CA2CA7CA9KMT2A | |
| SCHEMBL12552888 | 0.79 | KMT2A (0.58) | CA1CA2CA7CA9KMT2A | |
| SCHEMBL9480893 | 0.79 | KMT2A (0.62) | CA1CA2CA7CA9KMT2A | |
| SCHEMBL25032346 | 0.79 | KMT2A (0.62) | CA1CA2CA7CA9KMT2A | |
| SCHEMBL12552879 | 0.79 | KMT2A (0.58) | CA1CA2CA7CA9KMT2A | |
| SCHEMBL873616 | 0.78 | CA1 (0.61) | CA1CA2CA7CA9KMT2A | |
| SCHEMBL1096291 | 0.78 | CA1 (0.61) | CA1CA2CA7CA9KMT2A | |
| SCHEMBL2181772 | 0.78 | CA1 (0.61) | CA1CA2CA7CA9KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1904463-A2 | COMPLEXES CONTAINING PERFLUOROALKYL, METHOD FOR THE PRODUCTION AND USE THEREOF | Bayer Schering Pharma Aktiengesellschaft (DE) | 2008-04-02 | — | — | EP | disclosed |
| EP-1904462-A2 | COMPLEXES CONTAINING PERFLUOROALKYL, METHOD FOR THE PRODUCTION AND USE THEREOF | Bayer Schering Pharma Aktiengesellschaft (DE) | 2008-04-02 | — | — | EP | disclosed |
| EP-1856046-A1 | CONJUGATES OF METAL COMPLEX HYDROXYPYRIDIN DERIVATIVES AND BIOMOLECULES AND THE USE THEREOF FOR PRODUCING AGENTS USED IN NMR DIAGNOSIS | Bayer Schering Pharma Aktiengesellschaft (DE) | 2007-11-21 | — | — | EP | disclosed |
| EP-1828129-A1 | HYDROXYPYRIDINONE DERIVATIVES, THEIR METAL COMPLEXES AND THEIR USE IN THE PRODUCTION OF CONJUGATES WITH BIOMOLECULES | Bayer Schering Pharma Aktiengesellschaft (DE) | 2007-09-05 | — | — | EP | disclosed |
| WO-2007009638-A2 | COMPLEXES CONTAINING PERFLUOROALKYL, METHOD FOR THE PRODUCTION AND USE THEREOF | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2007-01-25 | — | — | WO | disclosed |
| WO-2007009637-A2 | COMPLEXES CONTAINING PERFLUOROALKYL, THEIR USE AS CONTRAST MEDIA FOR NMR, X-RAY AND RADIO DIAGNOSIS AND RADIOTHERAPY | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2007-01-25 | — | — | WO | disclosed |
| WO-2006069678-A1 | CONJUGATES OF METAL COMPLEX HYDROXYPYRIDIN DERIVATIVES AND BIOMOLECULES AND THE USE THEREOF FOR PRODUCING AGENTS USED IN NMR DIAGNOSIS | SCHERING AG (DE) | 2006-07-06 | — | — | WO | disclosed |
| WO-2006069676-A1 | HYDROXYPYRIDINONE DERIVATIVES, THEIR METAL COMPLEXES AND THEIR USE IN THE PRODUCTION OF CONJUGATES WITH BIOMOLECULES | SCHERING AG (DE) | 2006-07-06 | — | — | WO | disclosed |